EDUCATION and TRAINING:
2021-2024 Bachelor of Science; Medical Laboratory Science; Undergraduate
2020-2020 Graduated from secondary high school, Royesh high school, Arak, Iran
Completed with GPA: 3.96 (out of 4)
POSITIONS and PROFESSIONAL EXPERIENCE
Isfahan University of Medical Sciences, Iran | 2020-peresent
Position: Participant of student research team on Multiple Sclerosis
Responsibilities: I cooperate in designing and conducting research studies, data analysis, and scientific writing.
Isfahan University of Medical Sciences|2021-present
Position: Research assistant of Dr. Vahid Shaygannejad
Responsibilities: I involved in designing and performant of research subjects.
Awards
2018- Prominent Research Student at 34th Festival of the Best Researcher, Ministry Of Science, Iran
2019 - Best Student in the Province, 18th Best Student Festival, Iran.
2018 - Best Student in the Province, 18th Best Student Festival, Iran.
2017- First Student in Laboratory Completion in Country, Iran
2017- Third Oral Presentation of the International Congress on Stem Cells & Regenerative Medicine Focused On Clinical Applications & Economy
2017- Best Oral Presentation of 2th International Congress on Stem Cells & Regenerative Medicine Focused On Clinical Applications & Economy among Students
2016 - Best Student in the Province, 19th Best Student Festival, Iran.
Publications
PubMed publications
1. Sargazi, S., Er, S., Mobashar, A., Gelen, S. S., Rahdar, A.,
Ebrahimi, N., Hosseinikhah, S. M., Bilal, M., & Kyzas, G. Z. (2022). Aptamer-conjugated carbon-based nanomaterials for cancer and bacteria theranostics: A review.
Chemico-biological interactions, 361, 109964. https://doi.org/10.1016/j.cbi.2022.109964
2. Mirmosayyeb O, Naderi M, Raeisi S, Ebrahimi N, Ghaffary EM, Afshari-Safavi A, Barzegar M, Shaygannejad V. Hearing loss among patients with multiple sclerosis (PwMS): A systematic review and meta-analysis. Mult Scler Relat Disord. 2022 Jun;62:103754. doi: 10.1016/j.msard.2022.103754. Epub 2022 Mar 25. PMID: 35430545.
3. Mirmosayyeb O, Ebrahimi N, Barzegar M, Afshari-Safavi A, Bagherieh S, Shaygannejad V. Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis. PLoS One. 2022 Apr 19;17(4):e0266492. doi: 10.1371/journal.pone.0266492. PMID: 35439251; PMCID: PMC9017946.
4. Barzegar M, Mirmosayyeb O, Ebrahimi N, Bagherieh S, Afshari-Safavi A, Hosseinabadi AM, Shaygannejad V, Asgari N. COVID-19 Susceptibility and Outcomes among Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD): A Systematic Review and Meta-Analysis. Multiple Sclerosis and Related Disorders. 2021 Nov 1:103359.
5. Bagherieh S, Ebrahimi N, Mirmosayyeb O, et al. The First Case of Longitudinal Extensive Transverse Myelitis (LETM) Following the First Dose Vaccination with Sinopharm Vaccine. Authorea. January 27, 2022.
6. Khoshnood RJ, Zali A, Tafreshinejad A, Ghajarzadeh M,
Ebrahimi N, Safari S, Mirmosayyeb O. Parkinson’s disease and COVID-19: a systematic review and meta-analysis. Neurological Sciences. 2021 Nov 17:1-9.
7. Tavallaei MJ, Tavallaei AH, Ebrahimi N, Ghoshouni H, Afshari-Safavi A, Badihian S, Shaygannejad V, Mirmosayyeb O. The prevalence of Myocardial Infarction among Multiple Sclerosis Patients: a Systematic Review and Meta-analysis. Multiple Sclerosis and Related Disorders. 2021 Sep 30:103292.
8. Mirmosayyeb O, Ebrahimi N, Shekarian A, Bagherieh S, Afshari-Safavi A, Shaygannejad V, et al. Prevalence of dysphagia in patients with multiple sclerosis; a systematic review and meta-analysis. medRxiv [Internet]. 2021 Jan 1;2021.06.07.21258473. Available from: http://medrxiv.org/content/early/2021/06/08/2021.06.07.21258473.abstract
Local publications (BOOKS, Journal PUPLICATONS)
1. Mirmosayyeb.O, Chitsaz.A, Vaheb.S, Ebrahimi.N, Ghoshouni.H, Etesami.Z, (2021).”Successful live with Parkinson ,Vajhiran publication”
2. Mirmosayyeb.O,Shirani.K, Esmaeil.N, Nehzat.N, Tavalaie.MJ, Moases.E , Khalilian.P, Sadeghian.K, Saadat.M, Radandish.M,
Ebrahimi.N, Vaheb.S, Yahyazade.S. (2020).”COVID-19. Vajhiran publication”
Presentations
Oral presentation
Poster presentations
Under Review Manuscripts:
Some manuscripts which are under review:
1. Advances in nanotechnology versus stem cell therapy for the theranostics of Huntington’s disease (HD)
2. Advances in nanotechnology versus stem cell therapy for the theranostics of Multiple Sclerosis disease
3. Investigating the safety of Fampridine in patients with different stages of multiple sclerosis
4. Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transmission (EMT)
5. Insights Into the Interplay Between Epstein-Barr Virus (EBV) and Multiple Sclerosis (MS): A State-of-The-Art Review Multiple Sclerosis and Related Disorders
6. Prevalence Of Gastric Intestine In Covid-19 Children: Systematic Review And Meta-Analysis
7. Safety And Efficacy Of Rituximab In Covid-19 Patients: A Systematic Review Of Systematic Reviews
8. Safety And Efficacy Of Favipiravir In Covid-19 Patients: A Systematic Review Of Systematic Reviews
9. Prevalence Of Sexual Dysfunction Among Female Multiple Sclerosis Patients: Systematic Review And Meta-Analysis
10. Prevalence Of Rest Less Leg Syndrome Among Multiple Sclerosis Patients: Systematic Review And Meta-Analysis
11. Safety And Efficacy Of Stem Cell Therapy In Cerebral Palsy Treatment: A Systematic Review Of Systematic Reviews
12. Prevalence Of Multisystem Inflammatory Syndrome Children (MIS-C) Among Covid-19 Children: Systematic Review And Meta-Analysis
13. Alzheimer Disease and COVID-19: A Systematic Review and Meta-Analysis.
14. Safety Of Deep Brain Stimulation In Treating Multiple Sclerosis Patients: Systematic Review And Meta-Analysis
15. The Role Of Deep Brain Stimulation In Treating Multiple Sclerosis Tremor
16. The Effects Of Rituximab As A Risk Factor Of Malignancies In Multiple Sclerosis Patients: Systematic Review And Meta-Analysis
17. OCT-Cognition Systematic Review And Meta-Analysis
18. CNS demyelinating disease following inactivated or viral vector SARS-CoV-2 vaccines: a case series
19. COVID-19 vaccine may leads to cognitive impairment; a case report
20. Multiple Sclerosis Relapse following BBIBP-CorV (Sinopharm) COVID-19 Vaccine: A Presentation of Eight Cases from Iran
Technical and Research-Related Skills:
Laboratory Skills:
No items yet!
Member
24-Jan-18